This is due to the fact that in the process of tumor rejection induced by cyclopamine, immune downregulation is activated to produce interferon-γ (IFN-γ), thus inhibiting angiogenesis (Ibe et al., 2001). The gene discussed is IFNG; the disease is neoplasm.